Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | CD7-CART01 cells |
| Synonyms | |
| Therapy Description |
Limited information is currently available on CD7-CART01 cells, a putative chimeric antigen receptor (CAR) T-cell therapy targeting CD7 (Jun 2024). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| CD7-CART01 cells | CD7CART01 cells|CD7 CART01 cells | CD7 Immune Cell Therapy 4 | Limited information is currently available on CD7-CART01 cells, a putative chimeric antigen receptor (CAR) T-cell therapy targeting CD7 (Jun 2024). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06064903 | Phase Ib/II | Cyclophosphamide + Fludarabine CD7-CART01 cells | CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LL (CD7-CAR01) | Recruiting | ITA | 0 |